Annual Working Capital
$2.46 M
-$5.50 M-69.09%
April 30, 2024
Summary
- As of March 10, 2025, IPA annual working capital is $2.46 million, with the most recent change of -$5.50 million (-69.09%) on April 30, 2024.
- During the last 3 years, IPA annual working capital has fallen by -$32.39 million (-92.94%).
- IPA annual working capital is now -92.94% below its all-time high of $34.85 million, reached on April 30, 2021.
Performance
IPA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$66.90 K
+$178.10 K+160.16%
October 31, 2024
Summary
- As of March 10, 2025, IPA quarterly working capital is $66.90 thousand, with the most recent change of +$178.10 thousand (+160.16%) on October 31, 2024.
- Over the past year, IPA quarterly working capital has increased by +$178.10 thousand (+160.16%).
- IPA quarterly working capital is now -99.81% below its all-time high of $34.85 million, reached on April 30, 2021.
Performance
IPA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
IPA Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -69.1% | +160.2% |
| 3 y3 years | -92.9% | +160.2% |
| 5 y5 years | +144.8% | +160.2% |
IPA Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -92.9% | at low | -99.7% | +160.2% |
| 5 y | 5-year | -92.9% | +1591.2% | -99.8% | +140.6% |
| alltime | all time | -92.9% | +777.6% | -99.8% | +118.4% |
ImmunoPrecise Antibodies Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | $66.90 K(-160.2%) |
| Jul 2024 | - | -$111.20 K(-104.5%) |
| Apr 2024 | $2.46 M(-69.1%) | $2.46 M(-44.8%) |
| Jan 2024 | - | $4.45 M(-21.7%) |
| Oct 2023 | - | $5.69 M(-18.9%) |
| Jul 2023 | - | $7.02 M(-11.9%) |
| Apr 2023 | $7.96 M(-63.4%) | $7.96 M(-12.8%) |
| Jan 2023 | - | $9.13 M(-19.2%) |
| Oct 2022 | - | $11.30 M(-32.6%) |
| Jul 2022 | - | $16.76 M(-23.0%) |
| Apr 2022 | $21.77 M(-37.5%) | $21.77 M(-16.9%) |
| Jan 2022 | - | $26.19 M(-10.9%) |
| Oct 2021 | - | $29.38 M(-8.8%) |
| Jul 2021 | - | $32.22 M(-7.5%) |
| Apr 2021 | $34.85 M(<-9900.0%) | $34.85 M(+158.2%) |
| Jan 2021 | - | $13.50 M(+11.3%) |
| Oct 2020 | - | $12.12 M(+201.4%) |
| Jul 2020 | - | $4.02 M(-2537.8%) |
| Apr 2020 | -$165.00 K(-116.4%) | -$165.00 K(-119.1%) |
| Jan 2020 | - | $862.80 K(+41.4%) |
| Oct 2019 | - | $610.10 K(-43.3%) |
| Jul 2019 | - | $1.08 M(+7.0%) |
| Apr 2019 | $1.00 M(+159.0%) | $1.00 M(-81.1%) |
| Jan 2019 | - | $5.32 M(-14.7%) |
| Oct 2018 | - | $6.24 M(+1374.0%) |
| Jul 2018 | - | $423.40 K(+9.1%) |
| Apr 2018 | $388.00 K(-78.4%) | $388.00 K(-76.8%) |
| Jan 2018 | - | $1.67 M(-36.3%) |
| Oct 2017 | - | $2.63 M(+95.8%) |
| Jul 2017 | - | $1.34 M(-25.2%) |
| Apr 2017 | $1.80 M(-1127.0%) | $1.80 M(-30.3%) |
| Jan 2017 | - | $2.57 M(+1118.9%) |
| Sep 2016 | - | $211.20 K(-224.3%) |
| Jun 2016 | - | -$169.90 K(-6.4%) |
| Mar 2016 | - | -$181.60 K(+3.9%) |
| Dec 2015 | -$174.80 K(-4.1%) | - |
| Dec 2015 | - | -$174.80 K(+5.6%) |
| Sep 2015 | - | -$165.60 K(-2.5%) |
| Jun 2015 | - | -$169.90 K(-1.1%) |
| Mar 2015 | - | -$171.80 K(-5.7%) |
| Dec 2014 | -$182.20 K(+17.4%) | - |
| Dec 2014 | - | -$182.20 K(-8.6%) |
| Sep 2014 | - | -$199.30 K(+12.2%) |
| Jun 2014 | - | -$177.70 K(+21.4%) |
| Mar 2014 | - | -$146.40 K(-5.7%) |
| Dec 2013 | -$155.20 K(-30.2%) | - |
| Dec 2013 | - | -$155.20 K(+50.0%) |
| Sep 2013 | - | -$103.50 K(-57.5%) |
| Jun 2013 | - | -$243.60 K(+4.6%) |
| Mar 2013 | - | -$232.90 K(+4.8%) |
| Dec 2012 | -$222.20 K(+79.2%) | - |
| Dec 2012 | - | -$222.20 K(+28.4%) |
| Sep 2012 | - | -$173.00 K(+17.2%) |
| Jun 2012 | - | -$147.60 K(+10.9%) |
| Mar 2012 | - | -$133.10 K(+7.3%) |
| Dec 2011 | -$124.00 K(-182.1%) | - |
| Dec 2011 | - | -$124.00 K(+52.3%) |
| Sep 2011 | - | -$81.40 K(-554.7%) |
| Jun 2011 | - | $17.90 K(-85.4%) |
| Mar 2011 | - | $122.50 K(-18.9%) |
| Dec 2010 | $151.10 K | - |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | - | $151.10 K(-214.9%) |
| Sep 2010 | - | -$131.50 K(+120.6%) |
| Jun 2010 | - | -$59.60 K(+338.2%) |
| Mar 2010 | - | -$13.60 K(-129.0%) |
| Dec 2009 | $46.90 K(-90.2%) | - |
| Dec 2009 | - | $46.90 K(-63.4%) |
| Sep 2009 | - | $128.00 K(-21.0%) |
| Jun 2009 | - | $162.10 K(-25.8%) |
| Mar 2009 | - | $218.50 K(-54.6%) |
| Dec 2008 | $480.80 K(+4.5%) | - |
| Dec 2008 | - | $480.80 K(-51.4%) |
| Sep 2008 | - | $989.00 K(+364.8%) |
| Jun 2008 | - | $212.80 K(-29.1%) |
| Mar 2008 | - | $300.00 K(-34.8%) |
| Dec 2007 | $460.10 K(+980.0%) | - |
| Dec 2007 | - | $460.10 K(+8.8%) |
| Sep 2007 | - | $422.70 K(+24.8%) |
| Jun 2007 | - | $338.70 K(+1439.5%) |
| Mar 2007 | - | $22.00 K(-48.4%) |
| Dec 2006 | $42.60 K(-90.9%) | - |
| Dec 2006 | - | $42.60 K(-92.9%) |
| Sep 2006 | - | $603.10 K(-64.2%) |
| Jun 2006 | - | $1.68 M(+346.2%) |
| Mar 2006 | - | $377.40 K(-19.7%) |
| Dec 2005 | $470.00 K(-77.6%) | - |
| Dec 2005 | - | $470.00 K(-23.1%) |
| Sep 2005 | - | $611.00 K(-57.8%) |
| Jun 2005 | - | $1.45 M(-24.5%) |
| Mar 2005 | - | $1.92 M(-8.6%) |
| Dec 2004 | $2.10 M(+338.2%) | - |
| Dec 2004 | - | $2.10 M(+272.7%) |
| Sep 2004 | - | $563.30 K(-30.9%) |
| Jun 2004 | - | $815.30 K(-9.1%) |
| Mar 2004 | - | $896.60 K(+87.1%) |
| Dec 2003 | $479.10 K(+4597.1%) | - |
| Dec 2003 | - | $479.10 K(+79.2%) |
| Sep 2003 | - | $267.40 K(<-9900.0%) |
| Jun 2003 | - | -$1400.00(-103.5%) |
| Mar 2003 | - | $40.30 K(+295.1%) |
| Dec 2002 | $10.20 K(-111.8%) | - |
| Dec 2002 | - | $10.20 K(-66.1%) |
| Sep 2002 | - | $30.10 K(-43.8%) |
| Jun 2002 | - | $53.60 K(-142.4%) |
| Mar 2002 | - | -$126.40 K(+46.3%) |
| Dec 2001 | -$86.40 K(-76.2%) | - |
| Dec 2001 | - | -$86.40 K(-7.7%) |
| Sep 2001 | - | -$93.60 K(-577.6%) |
| Jun 2001 | - | $19.60 K(-105.9%) |
| Mar 2001 | - | -$333.40 K(-8.2%) |
| Dec 2000 | -$363.10 K(-282.7%) | - |
| Dec 2000 | - | -$363.10 K(-670.9%) |
| Sep 2000 | - | $63.60 K(-54.4%) |
| Jun 2000 | - | $139.40 K(-17.1%) |
| Mar 2000 | - | $168.10 K(-15.4%) |
| Dec 1999 | $198.70 K(-35.1%) | - |
| Dec 1999 | - | $198.70 K(-35.1%) |
| Dec 1998 | $306.10 K(-57.9%) | - |
| Dec 1998 | - | $306.10 K(-57.9%) |
| Dec 1997 | $727.80 K(-57.6%) | - |
| Dec 1997 | - | $727.80 K |
| Dec 1996 | $1.72 M | - |
FAQ
- What is ImmunoPrecise Antibodies annual working capital?
- What is the all time high annual working capital for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies annual working capital year-on-year change?
- What is ImmunoPrecise Antibodies quarterly working capital?
- What is the all time high quarterly working capital for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies quarterly working capital year-on-year change?
What is ImmunoPrecise Antibodies annual working capital?
The current annual working capital of IPA is $2.46 M
What is the all time high annual working capital for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high annual working capital is $34.85 M
What is ImmunoPrecise Antibodies annual working capital year-on-year change?
Over the past year, IPA annual working capital has changed by -$5.50 M (-69.09%)
What is ImmunoPrecise Antibodies quarterly working capital?
The current quarterly working capital of IPA is $66.90 K
What is the all time high quarterly working capital for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high quarterly working capital is $34.85 M
What is ImmunoPrecise Antibodies quarterly working capital year-on-year change?
Over the past year, IPA quarterly working capital has changed by +$178.10 K (+160.16%)